During a unique live virtual event on November 30, Johnson & Johnson Innovation will present its external collaboration model and meet innovative emerging companies and start-ups, as well as researchers, academics and organizations based in the UK and active in the pharmaceutical, medical device and consumer health sectors.

The event will include:

• An informative live in-conversation between Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, and Sir John Bell, Regius Chair of Medicine at the University of Oxford, hosted by Nerida Scott, Regional Head of Johnson & Johnson Innovation EMEA, on key topics for the UK life sciences and potential impact of the future of healthcare

• Testimonials from partner companies and organizations that have collaborated with Johnson & Johnson Innovation

• A briefing on the Johnson & Johnson Innovation collaboration model

• A call for proposals for innovators with a presence in the UK to meet with our team 1:1 and discuss collaboration opportunities

Johnson & Johnson Innovation works across the pharmaceutical, medical device and consumer health sectors to accelerate early-stage, transformational solutions by catalyzing the best ideas, wherever they are in the world. We do this by harnessing our deep scientific capabilities coupled with a wide range of tools, including customized deal structures, company creation, incubation and startup services, capital investments and other innovative business models that aim to meet the diverse needs of entrepreneurs, scientists and emerging companies. Our goal is to help life science and health technology innovations thrive through collaboration and partnership with the global ecosystem, so that together we can change the trajectory of human health.